바이오마커 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

The global demand for Biomarkers Market is presumed to reach the market size of nearly USD 148.09 BN by 2032 from USD 57.80 BN in 2023 with a CAGR of 11.02% under the study period 2024 - 2032.

Biomarkers are measurable indicators or substances that can be detected in biological samples and provide information about various physiological or pathological processes. Widely used in medical research and diagnostics, biomarkers can indicate the presence, progression, or response to treatment of diseases. Examples include proteins, genes, or specific molecules in blood or tissue. Biomarkers play a vital role in personalized medicine, aiding in identifying at-risk individuals, early disease detection, and monitoring treatment efficacy.

MARKET DYNAMICS

Biomarkers play a vital role in disease diagnosis, prognosis, and monitoring treatment responses, contributing to personalized medicine approaches. The surging burden of chronic diseases, such as cancer and cardiovascular disorders, fuels the market growth. Advances in genomics, proteomics, and metabolomics technologies contribute to identifying novel biomarkers, expanding the scope of their applications. Early disease detection, enabling timely interventions, improved patient outcomes, and growing emphasis on precision medicine and targeted therapies further propel market growth. Regulatory support for biomarker validation and approval processes enhances their integration into clinical practice. The rising investments in research and development for various diseases contribute to the market's continuous growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of biomarkers. The growth and trends of biomarkers industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the biomarkers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

• Consumables
• Services
• Equipment

By Type

• Safety Biomarkers
• Susceptibility/Risk Biomarkers
• Diagnostic Biomarkers
• Prognostic Biomarkers
• Monitoring Biomarkers
• Predictive Biomarkers
• Pharmacodynamic/Response Biomarkers

By Application

• Diagnostics
• Drug Discovery & Development
• Personalized Medicine
• Disease Risk Assessment
• Others

By Disease Indication

• Cancer
• Neurological Disorders
• Cardiovascular Disorders
• Infectious Diseases
• Immune Disorders
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Biomarkers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

• GLOBAL BIOMARKERS MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
• Global Biomarkers Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Biomarkers market include Abbott Laboratories, Agilent Technology, Becton, Dickinson and Company, Bio-Rad Laboratories, BioMerieux SA (Astute Medical), Merck KGaA, Qiagen NV, Quanterix, Quest Diagnostics, Thermo Fisher Scientific Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . BIOMARKERS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product & Service
  • 3.7.2 Market Attractiveness Analysis By Type
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By Disease Indication
  • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BIOMARKERS MARKET ANALYSIS BY PRODUCT & SERVICE

• 5.1 Overview by Product & Service
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product & Service
• 5.4 Consumables Historic and Forecast Sales by Regions
• 5.5 Services Historic and Forecast Sales by Regions
• 5.6 Equipment Historic and Forecast Sales by Regions

6 . GLOBAL BIOMARKERS MARKET ANALYSIS BY TYPE

• 6.1 Overview by Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Type
• 6.4 Safety Biomarkers Historic and Forecast Sales by Regions
• 6.5 Susceptibility/Risk Biomarkers Historic and Forecast Sales by Regions
• 6.6 Diagnostic Biomarkers Historic and Forecast Sales by Regions
• 6.7 Prognostic Biomarkers Historic and Forecast Sales by Regions
• 6.8 Monitoring Biomarkers Historic and Forecast Sales by Regions
• 6.9 Predictive Biomarkers Historic and Forecast Sales by Regions
• 6.10. Pharmacodynamic/Response Biomarkers Historic and Forecast Sales by Regions

7 . GLOBAL BIOMARKERS MARKET ANALYSIS BY APPLICATION

• 7.1 Overview by Application
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Application
• 7.4 Diagnostics Historic and Forecast Sales by Regions
• 7.5 Drug Discovery & Development Historic and Forecast Sales by Regions
• 7.6 Personalized Medicine Historic and Forecast Sales by Regions
• 7.7 Disease Risk Assessment Historic and Forecast Sales by Regions
• 7.8 Others Historic and Forecast Sales by Regions

8 . GLOBAL BIOMARKERS MARKET ANALYSIS BY DISEASE INDICATION

• 8.1 Overview by Disease Indication
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Disease Indication
• 8.4 Cancer Historic and Forecast Sales by Regions
• 8.5 Neurological Disorders Historic and Forecast Sales by Regions
• 8.6 Cardiovascular Disorders Historic and Forecast Sales by Regions
• 8.7 Infectious Diseases Historic and Forecast Sales by Regions
• 8.8 Immune Disorders Historic and Forecast Sales by Regions
• 8.9 Others Historic and Forecast Sales by Regions

9 . GLOBAL BIOMARKERS MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. South East Asia Sales Analysis
  • 9.5.10. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE BIOMARKERS COMPANIES

• 10.1. Biomarkers Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF BIOMARKERS INDUSTRY

• 11.1. Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Abbott Laboratories
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Agilent Technology
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Becton
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Dickinson and Company
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Bio-Rad Laboratories
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. BioMerieux SA (Astute Medical)
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Merck KGaA
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Qiagen NV
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. Quanterix
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments
• 11.12. Quest Diagnostics
  • 11.12.1. Company Overview
  • 11.12.2. Company Revenue
  • 11.12.3. Products
  • 11.12.4. Recent Developments
• 11.13. Thermo Fisher Scientific Inc.
  • 11.13.1. Company Overview
  • 11.13.2. Company Revenue
  • 11.13.3. Products
  • 11.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies